Answers are grounded in this paper and cite their sources.
A letter to the editor discussing the limitations of digoxin for rate control in atrial fibrillation, particularly its lack of efficacy during exertion.
Letters15 August 1991Digoxin: Mythology or Evidence?Rodney H. Falk, MDRodney H. Falk, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-115-4-329_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editors:I thank Dr. Zatuchni for his comments on our recent article on digoxin for atrial fibrillation (1, 2). I believe, however, that he has both missed the point and failed to take its message to heart. Contrary to his statement, we do understand why digoxin has been popular for 200 years. Its effects on resting heart rate in atrial fibrillation—the most obvious property of the drug—can be dramatic. We stress, however, that the natural human state is not one of perpetual rest and therefore that observations in the office do not necessarily reflect the behavior of the...References1. Zatuchni J. Requiem for Digoxin? [Letter]. Ann Intern Med. 1991;114:993. LinkGoogle Scholar2. FalkLeavitt RJ. Digoxin for atrial fibrillation: a drug whose time has gone? Ann Intern Med. 1991;114:573-5. LinkGoogle Scholar3. Jull-MollerEdvardssonRehnqvist-Alzberg SNN. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation. Circulation. 1990;82:1932-9. CrossrefMedlineGoogle Scholar4. PritchettMcCarthyWilkinson EEW. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. Ann Intern Med. 1991;114:539-44. LinkGoogle Scholar5. PietersenHelleman AH. Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Am J Cardiol. 1991;67:713-7. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston University School of Medicine Boston, MA 02118 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 15 August 1991Volume 115, Issue 4Page: 329-329KeywordsAtrial fibrillationBehaviorDrugsHeartHeart rate Issue Published: 15 August 1991 PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
Rodney H. Falk (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: